my dream jeopardy categories

i was going to take the night off, but…

salon on the coolness of start ups. i have no personal experience (yet!), but it seems coupland nailed this part of the zeitgeist in microserfs:

    "That's not the point, Abe."
    "What *is* the point, then?"
    "One-Point-Oh," I said.
    "What?" replied Abe.
    "Being One-Point-*Oh*. The first to do something cool or new."

the dot-coms meet the bio-info geeks. the story has a bit of detail about pangaea and celera, and also this tidbit:

Such are the capabilities of the computational biology that underlies bioinformatics -- a field that Francis Collins, director of the Human Genome Project for the National Institutes of Health, says he now often counsels promising graduate students to look to for career opportunities. "I just think it is going to hit us like a freight train and we really have too small a supply of expertise in that area," he said.
yah baby! show me the money...or the 1.0 opening. either one will do. now i just need to graduate...

here’s a question for the bio-geeks in the audience; i know you’re out there, i parse my logs regularly. (yes,, i’m talking to you 8^>=.) when you see a bioinfo paper without the source code, or a bioinformatics service provider, like i linked to last week, that doesn’t provide source, how do you evaluate the results they present? it seems to me like you can’t, but i’m curious as to the opinion of the field. i was surprised (but not really) today to find out that the software that affymatrix provides to interpret the data from their expression profiling chips is closed. if (when?) a bug gets found, what happens with all the papers based on data from those chips? maybe i should take this over to… thoughts, comments, flames to

much work to be done on the start page. suggestions welcome, of course.